BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 19726986)

  • 1. Can convective therapies improve dialysis outcomes?
    Locatelli F; Manzoni C; Cavalli A; Di Filippo S
    Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):476-80. PubMed ID: 19726986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relevance of convection in clinical practice: a critical review of the literature.
    Pozzoni P; Filippo S; Manzoni C; Locatelli F
    Hemodial Int; 2006 Jan; 10 Suppl 1():S33-8. PubMed ID: 16441866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantifying dialysis efficiency for middle molecules in haemodialysis and in convective and mixed techniques].
    Casino FG; Lopez T
    G Ital Nefrol; 2008; 25(1):66-75. PubMed ID: 18264920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R; Polkinghorne KR; Kerr PG
    Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Do convective treatments significantly reduce morbidity and mortality?].
    Manzoni C; Cavalli A; Pontoriero G; Di Filippo S; Locatelli F
    G Ital Nefrol; 2009; 26 Suppl 45():S16-9. PubMed ID: 19382089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cystatin C, beta2-microglobulin and C-reactive protein in hemodiafiltration and on-line endogenous liquid reinfusion and in low flux polysulphone bicarbonate conventional hemodialysis].
    Cristofano C; Vernaglione L; Perniola MA; Lo Barco C; Muscogiuri P; Chimienti S
    G Ital Nefrol; 2004; 21 Suppl 30():S197-200. PubMed ID: 15750984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advantages of new hemodialysis membranes and equipment.
    Vanholder R; Glorieux G; Van Biesen W
    Nephron Clin Pract; 2010; 114(3):c165-72. PubMed ID: 19955821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Are convective treatments equivalent to the traditional ones? The Hemo Study and beyond (review)].
    Altieri P; Sau G; Menneas A; Cabiddu G; Michittu MB; Mereu MC
    G Ital Nefrol; 2004; 21(3):245-53. PubMed ID: 15285003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convective dialysis therapies, current status and perspective.
    Ledebo I
    Ther Apher Dial; 2005 Jun; 9(3):223-7. PubMed ID: 15966994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of dialysis outcomes: experimental versus observational evidence.
    Locatelli F; Andrulli S; D'Amico M
    J Nephrol; 2001; 14 Suppl 4():S101-8. PubMed ID: 11798140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-leaking membranes for hemodialysis: a new class of membranes in search of an application?
    Ward RA
    J Am Soc Nephrol; 2005 Aug; 16(8):2421-30. PubMed ID: 15975998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Convective and mixed dialysis technique].
    Pedrini LA; Cozzi G
    G Ital Nefrol; 2007; 24(6):498-509. PubMed ID: 18278754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.
    Krieter DH; Hackl A; Rodriguez A; Chenine L; Moragues HL; Lemke HD; Wanner C; Canaud B
    Nephrol Dial Transplant; 2010 Jan; 25(1):212-8. PubMed ID: 19755476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent trials on hemodiafiltration.
    Locatelli F; Manzoni C; Del Vecchio L; Cavalli A; Pontoriero G
    Contrib Nephrol; 2011; 171():92-100. PubMed ID: 21625096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convective therapies for removal of middle molecular weight uremic toxins in end-stage renal disease: a review of the evidence.
    Thomas G; Jaber BL
    Semin Dial; 2009; 22(6):610-4. PubMed ID: 20017830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New dialysis therapy modalities: what role do they play in the hemodialysis patient's outcome?].
    Mandolfo S; Imbasciati E
    G Ital Nefrol; 2002; 19(1):22-30. PubMed ID: 12165942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matching efficacy of online hemodiafiltration in simple hemodialysis mode.
    Krieter DH; Hunn E; Morgenroth A; Lemke HD; Wanner C
    Artif Organs; 2008 Dec; 32(12):903-9. PubMed ID: 19133017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical dialysis: new problems and new prospects].
    Locatelli F; Manzoni C; Pozzoni P; Pontoriero G; Di Filippo L
    G Ital Nefrol; 2004; 21(2):156-64. PubMed ID: 15351950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MPO Study: just a European HEMO Study or something very different?
    Locatelli F; Gauly A; Czekalski S; Hannedouche T; Jacobson SH; Loureiro A; Martin-Malo A; Papadimitriou M; Passlick-Deetjen J; Ronco C; Vanholder R; Wizemann V;
    Blood Purif; 2008; 26(1):100-4. PubMed ID: 18182806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.